Abbott’s Plan For DBS Depression Therapy Wins FDA’s Breakthrough Designation

Abbott continued St. Jude Medical’s prior research on deep brain stimulation for treating depression and has advanced the technology far enough that the US FDA now believes it could be a breakthrough treatment for treatment-resistant depression.